Enhanced activation of the EGFR tyrosine kinase domain leads to the activation of intracellular signaling pathways such as the Raf/MEK/ERK and the PI3K/Akt pathways, which are ultimately responsible for the malignant phenotype of glioma cells. This evidence concerns the gene EGFR and central nervous system cancer.